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Carboxylate anions arising from collision-induced dissociation (CID) of the [M - 15]- ion 
produced by fast atom bombardment (FAB) of glycerophosphocholine (GPCho) were 
previously shown to be produced in an abundance ratio of 1:3 for the carboxylic acids 
estetied at sn - 1 and sn - 2, respectively. This observation has been confirmed in a 
series of 13 synthetic GPCho molecular species. A good correlation was found between the 
isomeric purity of GPCho molecular species as determined by negative-ion FAB/CID 
analysis and the isomeric purity of the sn - 2 fatty acid using a phospholipase A, assay. 
Negative-ion FAB mass spectra of several 1-0alkyl-2-acyl-GPCho molecular species were 
found to be similar to those of diacyl GPCho. However, the CID spectra from the major 
high-mass ions are different from those of the diacyl species in that the [M - 15]- ion 
yields only one carboxylate anion and the [M - 86]- undergoes a neutral loss of the sn - 2 
carboxylic acid as a major decomposition product. These results suggest several rules useful 
for structural characterization of GPCho molecular species by negative-ion tandem mass 
spectrometry (MS/MS): (1) For diacyl species, the mass of the two carboxyl anions plus the 
mass of the GPCho backbone (minus a methyl group) must correspond to the mass of the 
[M - 151 anion; (2) for diacyl species there is a carboxylate anion ratio approximately 1:3 for 
the substituents at sn - 1 and sn - 2; and (3) for alkylether species, only one fatty acyl 
group is present, and the difference between the [M - 151 ion and the GPCho backbone 
(minus methyl) plus the fatty acyl group at sn - 2 corresponds to an alkylether substituent. 
(4) Assignment of ether-linked molecular species can be made from the [M - 86]- ion, 
which has a strong neutral loss of the sn - 2 fatty acid. 
Analysis of GPCho isolated from human neutrophils by total lipid extraction and 
normal-phase HPLC was carried out by negative-ion FAB and MS/MS. The major arachido- 
nate-containing molecular species, which comprise only 5% of total GPCho, were identified 
by using precursor ion scans for the arachidonate anion, m/z 303. Decomposition of 
identified precursor ions permitted the assignment of those molecular species of GPCho 
that contain arachidonate at sn - 2 and identification of the substituent at the sn - 1 
position. These results were compared to previously identified molecular species from 
human neutrophils. Several minor arachidonate-containing molecular species were tenta- 
tively identified. (1 Am Sot Mass Specfmm 1991, 2, 45-54) 
G 
LYCEROPHOSPHOLIPIDS constitute a major 
fraction of the components of membranes 
within all mammalian cells [l]. Interest in 
these molecules has stemmed largely from the bio- 
physical properties they display in separating com- 
partments within cells and defming cellular bound- 
aries as well as their effect on membrane fluidity [2] or 
adaptations in composition due to temperature change 
[3]. More recently, however, it has become recognized 
that phospholipids aIso serve as precursors of biologi- 
cally active compounds that play important roles in 
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physiological regulation of complex cellular processes 
such as mediation of cell-cell communication [4, 51 
and intracellular receptor-signal transduction pro- 
cesses [6]. These regulatory substances are derived 
from phospholipids, so they are typically termed lipid 
mediators and fall into three general classes. One 
category contains the metabolites of arachidonic acid 
formed by the action of cyclooxygenase resulting in 
prostaglandins [7] or by action of 5-lipoxygenase re- 
sulting in leukotrienes [8]. A second class of lipid 
mediators are the platelet-activating factor (PAF) 
molecular species derived from phosphatidylcholines 
with a long-chain ether substituent at sn - 1 and a 
very short chain, typically acetate, at sn - 2 [9]. Third, 
diacylglycerols, derived from various phospholipids, 
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are known to activate protein kinase C and in this 
way participate in receptor-signal transduction [lo]. 
Whereas a great deal of information has been ob- 
tained concerning the biosynthesis of prostaglandins 
and leukotrienes from arachidonic acid and PAF 
biosynthesis from lyso-PAF (1-O-alkyl-sn-glycero- 
phosphocholine), we are only beginning to under- 
stand the complexities involved in the liberation of 
free arachidonic acid and ly~o-PAF from phospholipid 
precursors Ill]. The various membranes within cells 
are composed of complex mixtures of glycerophos- 
phocholines (GPCho’s).’ There are many phospho- 
lipid molecular species that may serve as precursors 
for free arachidonic acid and ly~o-PAF. Identification 
of the exact molecular species of phospholipids and, 
in particular, arachidonate-containing GPCho’s within 
a cell, has been a challenging analytical endeavor. 
Structures of two representative arachidonate-contain- 
ing GPCho molecular species, 1-octadecanoyl-Z 
arachidonoyl-GPCho and 1-octadecyl-2-arachidonoyl- 
GPCho, are shown here as Structures I and II, respec- 
tively. 
In 1986, Jensen et al. [12] suggested that fast atom 
bombardment (FAB) and tandem mass spectromeh-y 
(MS/MS) could be effective in identifying 
molecular species of glycerophospholipids, including 
GPCho. They used a three-sector mass spectrometer 
with an electric sector to analyze the product ions 
following coIlision-induced decomposition (CID) of 
negative ions from GPCho. The resolution of this 
instrument for daughter ions was approximately 100, 
which limited to some extent the ability to analyze 
fatty acyl components of phospholipids that differ by 
a single double bond. In 1988, Munster and 
Budzikiewicz [13] cotimed these observations and 
extended the analysis to 11 molecular species of glyc- 
erophosphatidylcholine that differed in fatty acyl 
groups at sn - 1 or sn - 2. The present work extends 
these reports by addressing the analysis of arachido- 
‘Abbreviations used: sn - 1 and sn - 2, stereospecifically numbered 
positions 1 and 2 on the sn-Gl’Cho backbone (also, the identity of 
the fatty acids in the sn - 1 and sn - 2 positions are indicated by 
the numerical order in which they are written, for example, 
16:0e/20:4 GPCho, where 169 represents a 16carbon fatty acid with 
no double bonds, and 20~4 represents a 20-carbon fatty acid with 
four double bonds. The lowercase letter following the sn - 1 fatty 
acid indicates the type of linkage at sn - 1, either, a, e, or p 
representing acyl, ether, or vinyl ether, which is commonly referred 
to as plasm&g+; PAF, platelet-activating factor; PLA,, phospholi- 
pase A,; TRIS, tris(hydroxymethyl)-aminomethane; CID, collision- 
induced dissociation. 
nate-containing molecular species and 1-0-alkyl ether 
phosphatidylcholines. Furthermore, MS/MS with bet- 
ter product ion resolution is used to identify molecu- 
lar species in a biological extract. 
Methods and Materials 
Materials 
Phospholipid molecular species were purchased from 
Avanti Polar Lipids (Birmingham, AL) or from Sigma 
ChemicaI Company (St. Louis, MO). All lipids were 
used without further purification. Solutions in chloro- 
form were made between 0.25 and 1.0 pg/pL. Phos- 
pholipase A, (from Crotulus ahnunteus) was obtained 
from Sigma Chemical Company. 411 other reagents 
were commercially obtained in the purest grade possi- 
ble. 
Mass Spectromet y 
Mass spectra were obtained on a Finnigan TSQ70B 
(San Jose, CA) triplequadrupole mass spectrometer 
equipped with a saddle-field FAB gun by Ion Tech 
(Middlesex, England). Xenon was used as the particle 
source with a typical accelerating potential of 5 kV at 1 
mA. Argon was used in the second quadrupole (42) 
collision cell at a pressure of 0.5 mtorr. Collision 
energy offset (El=,,) of 30 eV was used to induce 
dissociations (CID). The instrument was equipped 
with a conversion dynode, which was set at 12 kV for 
these experiments. Typically, hve product ion scans 
(from m /z 150 up to 20 u higher than the mass of the 
selected precursor ion, in 2 s) were averaged for each 
ion decomposed. A precursor ion scan of m/z 303 
was used to determine the arachidonate-containing 
molecular species in the neutrophil GPCho fraction. 
Subsequent product ion scans were then obtained for 
each precursor of m/z 303. 
Isomeric purity (X; mole fraction of specified posi- 
tional isomer) of GPCho molecular species was calcu- 
lated from the observed intensity ratio (R) of the 
FABjMS /MS carboxylate anions from sn - 1 and 
sn - 2 by using the equation 
X = ;(3 - R)/(R + 1) 
where R is the intensity ratio for R&00- /R&00-, 
and R&00- is identified by being more abundant 
than &COO-. This equation was derived by assum- 
ing that an absolute carboxylate anion Intensity ratio 
of 1:3 would be observed for a pure positional isomer. 
Phospholipuse A, Assay 
An assay involving the use of phospholipase A, 
(PLA,) was performed to determine the purity of the 
positional isomer of each synthetic GPCho molecular 
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species. Phospholipid, 50-100 pg, in CHCl, solution, 
was transferred to screw-cap glass tubes and dried 
under a stream of dry nitrogen at 37 ‘C, followed by 
addition of a small volume of diethyl ether, which 
was reevaporated to remove traces of CHCl,. The 
residue was reconstituted in 2 mL of diethyl ether, 
and a mixture of PLA, (100 units in 50 PL of ‘IRIS 
buffer), TRIS buffer (100 BL of 0.2 M, pH 7.5), calcium 
chloride (40 bL, 0.1 M), and distilled water (210 pL) 
was then added to the ether in each tube. The test 
tubes were sealed with Teflon-limed caps and vor- 
texed continuously for at least 3.5 h to create inverted 
micelles, which increase the ether-aqueous interfacial 
surface area at which the reaction between the sub- 
strate and the enzyme occurs. Without separation of 
layers, the ether was evaporated, and the remaining 
aqueous layer was acidified with a drop of glacial 
acetic acid and extracted three times with two vol- 
umes of hexane. The hexane-extracted fatty acids were 
converted to methyl esters with diazomethane. 
Fatty acid methyl esters were analyzed by gas chro- 
matography by using flame ionization detection. The 
detector was heated to 280 ‘C, and the injector to 
250-280 “C. Splitless injection was used with no purge 
flow for 0.5 min after injection. The fused-silica capil- 
lary column (DB-1, 10 m x 0.25 mm i.d., 0.25 pm film 
thickness; J & W Scientific, Ranch0 Cordova, CA) was 
operated with helium carrier gas at a head pressure of 
7 psi. The temperature program was from 120 to 180 
‘C at 30 ‘C/min, then from 180 to 260 ‘C at 5 
“C/min. Relative peak areas were determined, and 
areas were converted to mole % fatty acid using 
relative response factors [14]. Fatty acid methyl ester 
identification was conhrmed by GC/MS (EI, 70 eV). 
Isolation of Glycerophosphocholine from 
Neutrophils 
Neutrophils were isolated from human blood as pre- 
viously descrrbed [15]. A total lipid extract of approxi- 
mately 200 x lo6 neutrophils was carried out accord- 
ing to the method of Bligh and Dyer [16] with 20 mL 
of CHCl, /MeOH. Solid butylated hydroxytoluene (25 
mg) was added to the chloroform layer to prevent 
oxidation of the lipids. After removal of the chloro- 
form under vacuum, the extract was reconstituted in 
mobile phase for normal-phase high-performance liq- 
uid chromatography (NP-HPLC) pwihcation. The 
mobile phase used for the separation of the phospho- 
lipid classes consisted of a gradient from 47% solvent 
A (hexane/isopropanol; 3/4, v/v) held for 6 rnin, 
changing to 100% solvent B (hexane/ 
isopropanol/water; 3/4/0.7, v/v/v) over a 20-min pe- 
riod. The flow rate was 1 mL/min. The NFWPLC 
column used was a 4.6 mm x 25 cm silica column 
with 5 brn particle size from Alltech Applied Science 
(State College, PA). The elution of the phospholipid 
classes was monitored with a UV detector set to 
monitor absorption at 206 run. 
Results 
Three abundant high-mass negative ions are pro- 
duced upon FAB ionization of diacyl GPCho molecu- 
lar species as noted by others [12, 131. These anions 
correspond nominally to [M - 151 (loss of CH,), [M 
- 601 (loss of HN(CH,),), and [M - 861 (loss of 
CH,CHN(CH,),), as seen for the molecular species 
l-octadecanoyl-2-arachidonoyl-sn-gIycerophosphati- 
dylcholine (I) in Figure la. Previous work in this 
laboratory has indicated that formation of the demeth- 
ylated ion [M - 151 involves the initial formation of a 
matrix-phospholipid adduct ion that also decomposes 
to the two additional high-mass ions [17]. This ac- 
counts for the fact that neither the [M - 601 nor the 
[M - 861 ions are produced upon collisional activation 
of the [M - 15) ion directly (see Figure lb). However, 
it is also possible that some of the [M - 601 ion is 
produced through ~-elimination (Hoffman reaction) 
of the phospholipid in the condensed phase, induced 
by the xenon atom beam. When each of these major 
high-mass ions is collisionally activated, abundant 
carboxylate anions are observed. Decomposition of 
the [M - 151 (Figure lb) ion as well as the [M - 601 
(Figure Ic) ion yields two carboxylate anions (m/z 283 
and 303) in a relative abundance ratio of 1:3. These 
m/z values correspond to the stearate and arachido- 
nate carboxylate anions. Decomposition of the [M - 
861 (Figure Id) ion leads also to the generation of 
these two carboxylate anions, but with an abundance 
ratio opposite to that observed for the decompositions 
of [M - 151 and [M - 601, that is, 3:l for sn - 1:sn - 
2. In addition, significant ions from [M - 861 are ob- 
served at m /z 419 and 437, corresponding to the loss 
of &Hz,- CH = C = 0 and CigH,-COOH, re- 
spectively (i.e., loss of the alkyl ketene and the car- 
boxylic acid moiety esterified at sn - 2). 
The CID spectra of several commercially available 
diacyl GPCho molecular species are summarized in 
Table 1. As noted previously [12], the abundance of 
the carboxylate anions resulting from the fatty acid 
esteritied at the sn - 1 position relative to the sn - 2 
position should be in a ratio of 1:3 in the CID of 
[M - 15]-. This ratio has been thought to reflect the 
relative rates of formation of the carboxylate anions by 
the CID process. However, for most of the molecular 
species measured in Table 1, the ratio of the abun- 
dances of sn - l:sn - 2 carboxylate anions was sig- 
nificantly higher than 1:3. One possible reason for 
this difference was the presence of positional isomers 
of the molecular species in these commercial, syn- 
thetic phospholipids. Other explanations for the ob- 
served ratios may include the use of low energy for 
the CID process, the effect of unsaturation ln fatty 
acyl groups, or the effect of the chain length of each 
acyl substituent on the decomposition. 
To assess the isomeric purity of the fatty acyl groups 
at sn - 2 of the phospholipid species, specific hydrol- 
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Figure 1. Fast atom bombardment mass spectrometry of l-oc- 
tadecanoyl-2-arachidonoyl-sn-glycerophosphatidylcholine: (a) 
High-mass negative ions produced by FAB; m/z 794, 749, and 
723, correspond to [M - CH,]-, [M - HN(CHs),] -, and [M - 
CH,=CHN(CH,),]-, respectively; (b) CID MS/M5 of [M - 
CH,]-; (c) CID of [M - HN(CH,),]-; (d) CID of [M - 
CH,=CHN(CH&-. CID conditions were 0.5 mtorr argon and 
E, of 30 ev. 
ysis was carried out with the enzyme PLA, [18]. 
Liberated fatty acids were methylated and then ana- 
lyzed by gas chromatography. The measured komeric 
purity (as determined by PLA, assay) is compared 
with that based upon the observed ratio of the carbox- 
ylate anions obtained by negative FABjMS/MS (CID 
of [M - 151) in Figure 2. The mass spectrometric re- 
sults were calculated, assuming that the expected 
positional isomer would result in a 1:3 abundance 
ratio of carboxylate anions for sn - 1: sn - 2 from CID 
of the [M - 151 ions. Similar results for the calculated 
purity were obtained using 1:3 abundance ratios for 
[M - 601 ions and 3:l for the [M - 861 ions. 
Several of the synthetic phospholipids contained 
significant amounts of positional isomers. There was a 
signlfrcant linear correlation (Y = 0.87; p = 0.0001) be- 
tween the measured purity of molecular species by 
mass spectrometry and the purity of the molecular 
species as assessed by enzymatic hydrolysis (Figure 
2). It is of interest to point out that although the slope 
of this line was close to unity, the intercept was 
nonzero ( y = 0.73x + 0.36). Nevertheless, a reason- 
able estimate of the sn - l:sn - 2 fatty acyl substitu- 
tion can be obtained from direct mass spectrometric 
analysis by CID of the [M - 151 anions with assess- 
ment of the ratios of carboxylate anion intensities. 
In addition to the diacyl molecular species of GP- 
Cho, several 1-0-alkyl-2-acyl molecular species were 
examined. These mass spectra are tabulated in Table 
2. The high-mass ions generated by FAB/MS/MS are 
analogous to those previously observed and reported 
for diacyl species of GPCho, as can be seen in Figure 
3a, which shows FAB spectra of 1-0-octadecyl-2- 
arachidonoyl GPCho (II). However, only one carbox- 
ylate anion (m /z 303) is produced upon CID of the 
[M - 151 (Figure 3b) and [M - 601 (Figure 3c) ions 
from 18:0e/20:4-GPCho, because there is only one 
fatty acid ester moiety (arachidonoyl) in this molecule. 
Cleavage of the t-0-aIky1 bond is not observed during 
the FAB process or after CID of source ions. How- 
ever, CID of the [M - 861 (m/z 709, Figure 3d) ion 
results in a rather intense ion corresponding to loss of 
the R,COOH (m /z 405) and only a minor ion corre- 
sponding to the carboxyIate anion at sn - 2 (m/z 
303, Figure 3d). The appearance of these ions is sub- 
stantially different from those observed for decompo- 
sitions of the corresponding ion in the diacyl species. 
The neutral loss of the R,COOH further conhrms the 
identity of the molecular species as a I-0-alkyl-2-acyl- 
GPCho as well as the exact assignment of the fatty 
acy1 group at srz - 2. 
Arachidonoyf Molecular Species in the Human 
Neufrophil 
Analysis of the human neutrophil GPCho by FAB/MS 
reveals a complex mixture of molecular species as 
shown in Figure 4a. Those ions that occur at even 
masses can correspond to [M - 15]-, whereas the 
ions at odd masses correspond to either the [M - 60- 
or [M - 86]- species. From the abundances of the 
[M - 151 anions, the major molecular species of GP- 
Cho in the human neuhophil are evident. The ions 
represented by m/z 770, 744, and 730 likely corre- 
spond to the major diacyl and alkylacyl species, 
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Table 1. Relative intensities of the product ions from the fatty acyl groups following CID of the precursor 
ions [M - 151, pd - M)], and [M - 861 from 1,ZdiacyLGPCho molecular speciesa 
Precursor: [M - 151- [M - 601- [M - 861~ 
Produmb: R,COO~/R,COO- R,COOm/R,COOm R,COO~/R,COO- -R,=C=O/R,COO- -R,COOH/R,COO- 
Molecular 
species MW 
16:Oa/l4:0 705 0.70 0.65 0.58 0.20 0.25 
14:0a/lE:O 705 0.48 0.46 0.62 0.23 0.33 
14:0e/l8:0 733 0.45 0.47 0.80 0.20 0.35 
18:0a/l4:0 733 0.78 0.70 0.50 0.18 0.22 
16:0a/18:2 757 0.34 0.37 0.46 0.26 0.36 
16:0a/18:1 759 0.45 0.43 0.54 0.20 0.30 
18:la/l&O 759 0.34 0.37 0.34 0.15 0.25 
16:0a/l8:0 761 0.47 0.53 0.68 0.22 0.35 
1 %:Oa/l6:0 761 0.70 0.68 0.57 0.18 0.30 
18:0a/l8: 1 787 0.38 0.35 0.38 0.18 0.20 
18:la/l&O 787 0.33 0.41 0.39 0.20 0.19 
16:0a/20:4 781 0.56 0.56 0.42 0.31 0.49 
18:0a/20:4 809 0.43 0.52 0.33 0.15 0.20 
‘Synthetic phospholipids commercially available. Indicated molecular species may be impure owing to acyl migration during synthesis. 
bR,CCIO-, fatty acyl group esterified at sn - 1; R,COO-, fatty ac~l group esterified at sn - 2; -R,=C=O, loss of sn - 2 acyl group as 
ketene from the [M 861 ion; R,COOH, loss of sn - 2 carboxylic acid from the [M - 861 mn. 
whereas the ions at m/z 699, 673, and 659 then 
correspond to [M - 861 of these molecular species. It 
is difficult to uniquely assign an odd-mass ion, be- 
cause a mass difference of only 26 between [M - 861 
and [M - 601 is the same mass difference as is ex- 
80 
60 
16:0/l 8:2 q  
/ 
q  18:0/20:4 
/ 
16:0/20:4 
I . I . I . I I . 
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1 
80 90 100 
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Figure 2. Comparison of the mole fractions of GPCho posi- 
tional isomers in commercial synthetic GPCho molecular species 
as determined by negative FAB/CID and by F’LA, analysis of 
the sn - 2 fatty acid(s). Mole fractions calculated using the 
FAB/CID data assumed that CID analysis of a pure positional 
isomer would produce carboxylate anions t&m sn - 1 and 
sn - 2 in an abundance ratio of 1:3. 
petted for an additional two-carbon chain with one 
more degree of unsaturation, which is typically found 
for homologous lipids in naturally occurring GPCho 
extracts. 
Precursor ion scans for individual carboxylate an- 
ions readily reveal those molecular species that con- 
tain the specified fatty acyl group esterified either at 
sn - 1 or sn - 2. For example, Figure 4b and c are 
precursor scans for m/z 281 (oleate) and m/z 303 
(arachidonate), respectively. The most abundant dia- 
cyl-containing molecular species (Figure 4a) appear at 
m/z 772 and 744, which correspond to the dioleoyl 
and palmitoyl-oleoyl molecular species of GPCho. The 
example for arachidonic acid (Figure 4c) is interesting 
in that all of the precursor ions are minor con- 
stituents, comprising only 5% of the total GPCho [19] 
with [M - 151 anions at m jz 750, 752, 766, 778, 780, 
792, 794, and 806. Other minor species that contain 
arachidonate are also indicated by the precursor scan. 
Assignment of structures corresponding to each of 
these precursors can be accomplished by employing 
observations made from the MS/MS of [M - 151 an- 
ions: (1) For diacyl species, the mass of the two 
carboxylate anions (from the CID experiment) plus 
the mass of the GPCho backbone (minus a methyl 
group) must correspond to the mass of the [M - 151 
anion; (2) for diacyl species, there is a carboxylate 
anion ratio of 1:3 for the substituents at sn - 1 and 
sn - 2; and (3) for alkyl ether species, only one car- 
boxylate anion is produced in the CID experiment, 
and the difference between the [M - 151 ion and the 
GPCho backbone (minus methyl) plus the carboxylate 
anion from sti - 2 corresponds to the sn - 1 alkyl 
ether substituent. To obtain information concerning 
the above points, it is necessary to carry out a product 
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Figure 3. Fast atom bombardment mass spectrometry of I-O- 
octadecyl-Z-arachidonoyl-sn_GPCho: (a) High-mass negative ions 
produced by FAB; m/z 780, 735, and 709, correspond to [M - 
CH,] -, [M - HN(CH,),] -, and [M - CH, =CHN(CH,),] -, 
respectively; (b) CID MS/MS of [M - CHJ; (c) CID of [M - 
HN(CH,)$; (d) CID of [M - CH,=CHN(CH,)J with the 
base peak at m/z 405 representing a neutral loss of acachidonic 
acid from sn - 2. 
Discussion 
A determination of phospholipid molecular species 
that contain esterifred arachidonic acid is necessary 
for establishing a metabolic relationship between po- 
tential phospholipid precursors and arachidonic acid 
metabolites such as prostaglandiis and leukotrienes. 
It has been suggested that arachidonate, which ulti- 
mately is converted into either prostaglandins or 
leukotrienes, is derived from a unique phospholipid 
molecular species precursor that contains a 1-0-alkyl 
substihrent at sn - 1 and arachidonate esterifred to 
sn - 2 [ll]. To investigate the existence of such a 
unique molecular species precursor, it is important to 
have the capability of analyzing complex mixtures of 
phosphatidylcholines that contain arachidonate esteri- 
fred in different molecular species. 
The usual method for the identification of phos- 
pholipid molecular species involves stages of separa- 
tion including normal-phase chromatography to iso- 
late classes of phospholipids on the basis of their 
polar head groups (phosphatidylcholine, phos- 
phatidylinositol, phosphatidylethanolamine, phos- 
phatidylserme, and phosphatidic acid). Individual 
molecular species can then be separated on the basis 
of the fatty acyl groups esterifred to sn - 1 and srr - 2 
by RF’-HPLC [22]. Typically, identihcations of the ex- 
act molecular species are based upon relative reten- 
tion times. Because the separation of molecular species 
is based upon the cumulative effects of the hydropho- 
bic nature of the fatty acyl substituents, complete 
separation of molecular species of phospholipids from 
natural sources is virtually impossible. Therefore, de- 
velopment of alternative analytical approaches with 
the ability to identify minor molecular species that 
might coelute or elute very close to major phospho- 
Lipid molecular species has become essential. Chemi- 
cal or enzymatic degradation of separated phospho- 
lipid molecular species with subsequent GC analysis 
of methyl esters is often employed to identify the 
specific fatty acyl groups, for example, esterifred at 
sn - 2. However, this process is lengthy and tedious 
and fails to distinguish between the potential compo- 
nents at sn - 1 being an I-0-alkyl ether, l-O-alk-l’- 
enyl ether, or 1-acyl ester component, because the 
molecular weight of the intact molecule is not mea- 
sured. An alternative method has involved the use of 
phospholipase C [23] or chemical techniques [24] to 
cleave the polar head group, yielding a diglyceride 
that can be derivatized into an appropriate derivative 
for further chromatographic separation. Fdr example, 
diglycerides can be analyzed by HPLC or mass spec- 
trometric techniques [25]. 
With the development of alternative methods of 
mass spectrometric analysis including thermospray 
and FAB ionization, more direct methods have be- 
come feasible for phospholipid analysis. These meth- 
ods are especially attractive because of the specific 
information that can be obtained from the mass spec- 
trum and the potential for direct molecular species 
analysis. Thermospray mass spectrometry has been 
demonstrated to be useful for online HPLC detection 
of phospholipid molecular species [26]. However, 
identity of positional isomers and the assignment of 
sn - 1 and sn - 2 are not afforded by this technique. 
Fast atom bombardment has been particularly useful 
for the identification of molecular species of various 
phospholipid classes [12, 131. High-mass positive ions 
[M + H] + for phosphatidylcholine, phosphatidyleth- 
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GPCho 
Figure 4. Negative FAB/MS and MS/MS spectra ob- 
tained from the GPCho fraction isolated from human 
neutiophii. (a) High-mass negative ions produced 
t&n the mikure of GlTho molecular species. (b) 
Precursors of m/r 281, corresponding to those ions 
arising from molecular species that contain esterSed 
oleic acid (18:l). (c) Precursors of m/z 303, correspond- 
ing to those ions arising from molecular species that 
contain esterified arachidonic acid (20:4). 
Precursors 
m/z 281 
(l&l) 
E 60 - 
699 
772 
9 730 40 * 756 
_- 
673 726 
650 ?W 750 600 950 900 
anolaminc, and phosphatidylserine, indicating the 
molecular weight, can be obtained by FAB ionization. 
High-mass negative ions [M - 151, [M - 601, and [M 
- 861 also indicate the molecular weight of the intact 
GPCho molecular species in somewhat less abundant 
yields. However, the negative FAB mass spectrum 
also contains intense carboxylate anions that corre- 
spond to the esteritied fatty acyl groups in the phos- 
pholipid molecular species. As suggested by others 
[12, 131 and further confnmed by this report, the 
position of the fatty acyl groups on the glycerol back- 
bone can be readily determined by the use of negative 
FAB with MS/MS. Tandem mass spectrometry also 
eliminates the need to carry out reverse-phase separa- 
ItlO- c 
SO- 
60- 
778 Precursors 
752 ml2 303 
(20:4) 
780 
794 
700 750 800 850 900 950 
m/z 
tion of individual molecular species, because the first 
mass spectrometer sector, either a quadrupole or 
magnetic sector instrument, can separate phospho- 
lipid molecular species through specific, characteristic 
ions. Therefore, the qualitative analysis of phospho- 
lipid molecular species is quite feasible by 
FAB/MS/MS. 
Collision-induced dissociation of the high-mass 
negative ions results in the formation of carboxylate 
anions in abundance depending upon the site of es- 
ter&cation. The anions from fatty acyl moiety at 
sn - 2 are approximately three times more abundant 
than that from the sn - 1 carboxylate anion. The 
reports published so far are consistent with this obser- 
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m/z 
60 
40 
20 
0 
vation except for the case where the group at sn - 2 
is quite small, for example acetate, in which case a 
weaker signal for m /z 59 has been reported [13]. One 
suggestion for the abundant formation of sn - 2 an- 
ion has been the release of steric strain in the decom- 
position mechanism while the sn - 1 anion is being 
formed by an sni mechanism that involves the phos- 
phate oxygen displacing the carboxylate anion 1131. 
We would like to suggest that there may be many 
mechanisms responsible for the observed sr~ - 2: sn - 
1 anion ratios and therefore a slope for the correlation 
time in Figure 2 different from unity. An alternative 
process could involve competition for the phosphate 
oxygen attacking either at sn - 1 or sn - 2, forming a 
six-membered cyclic transition state or five-membered 
cyclic transition state, with the five-membered cyclic 
transition state being highly favored. This would in- 
crease the abundance of the carboxylate anion arising 
from sn - 2 (five-membered cyclic phosphate ester) 
relative to the anion from sn - 1 (six-membered cyclic 
phosphate ester). 
Figure 5. Product ion scans for two 
major precursor ions of m/z 303 found 
in the GPCho fraction from human neu- 
trophiis. (a) m/z 794, corresponding to 
l-octadecanoyl-2-arachidonoyl-sn- 
glycerophosphatidylcholine. Other car- 
boxylate anions correspond to isobaric 
molecular species (see text). (b) m/z 780, 
corresponding to l-O-octadecyl-2- 
arachidonoyl-sn-GPCho. Carboxylate an- 
ions for other molecular species are pre- 
sent from other isobaric molecular species 
(see text). 
We have found that the observed ratio of the abun- 
dances of sn - 1:sn - 2 is 1:3 by this low-energy CID 
process for a variety of diacyl-GPCho molecular 
species, including some containing estertied arachi- 
donic acid. An observed deviation from this ratio 
suggests the presence of a mixture of molecular 
species, even positional isomers. The linear correla- 
tion found for the ratio of the sn - 1:sn - 2 abun- 
dances relative to PLA, analysis supports the idea 
that collisional activation of [M - 15]- as well as 
[M - 60]- anions can provide a key piece of informa- 
tion that permits analysis of the complex mixture of 
GPCho molecular species found in biological extracts. 
However, the lack of complete agreement for these 
two measurements argues for several mechanisms 
operating in the formation of carboxylate anions by 
collisional activation. 
The results of the analysis of GPCho molecular 
species from human neutrophils containing arachi- 
donic acid by FAB/MS/MS compare favorably with 
those obtained by traditional and more laborious tech- 
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Table 3. Comparison of identifwation of GPCho molecular species containing estertied arachidonic acid, in human neutrophils 
Human neutrophil 
GPCho molecular species 
Literaturea FAB/CIDb 
18:0a/20:4 19:Oa/20:4 
19:1a/20:4 19:1a/20:4 
18:Oe/20:4 18:Oe/20:4 
18:le/20:4 18: le/20~4~ 
18:Op/2034 
16:0a/20:4 16:0a/20:4 
16:0e/20:4 lB:Oe/20:4 
1 B:Op/20:4 lB:Op/20:4 
20: le/20:4d 
2O:Oe/20:4 
22:le/20:4d 
Precursors of m/z 303b 
794 
792 
780 
778 
766 
752 
760 
806 
808 
834 
% Relative abundance of 
precursors of m/z 303 
64 
27 
62 
100 
44 
86 
30 
22 
16 
16 
‘Identified by RF-HPLC separation and FAB/MS [20. 211. 
bldentified from precursor ion scan using negative FAS/MS/MS shown in Figure 4~. 
‘Assignment of double-bond position in the alkyl group at sn - 1 is not possible with MS /MS. These species may be plasmalogens. and 
byth have been described in the kterature 120. 211. 
Assignment of double-bond position in the alkyl group at sn - 1 is not possible with MS/MS. 
niques including normal-phase and reverse-phase 
chromatographic separations and partial degradation. 
The eight major arachidonate-containing molecular 
species were readily detected, including both diacyl 
and alkyl ether subclasses. In addition, other minor 
molecular species not previously characterized could 
be detected. Although this approach has been illus- 
trated with identification of arachidonate-containing 
molecular species, it is, of course, possible to screen 
for any other fatty acyl group present in the complex 
phospholipid mixture. Furthermore, precursor scans 
permit the determination of relative abundances of 
those molecular species that contain arachidonic acid, 
which is difficult to assign except by quantitative 
analysis of the arachidonate content following separa- 
tion of each molecular species. 
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